Treatment with siRNA and antisense oligonucleotides targeted to Hif-1α induced apoptosis in human tongue squamous cell carcinomas

被引:80
作者
Zhang, QZ
Zhang, ZF
Rao, JY
Sato, JD
Brown, J
Messadi, DV
Le, AD
机构
[1] Drew Univ Med & Sci, Dept Oral & Maxillofacial Surg, Los Angeles, CA 90059 USA
[2] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA
[3] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90024 USA
[4] Mt Desert Isl Biol Lab, Salsbury Cove, ME USA
[5] Charles R Drew Univ Med & Sci, Dept Head & Neck Surg, Los Angeles, CA 90059 USA
[6] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA
关键词
antisense; siRNA; apoptosis; HIF-1; alpha; Bcl-2; IAP-2;
D O I
10.1002/ijc.20334
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Overexpression of hypoxia inducible factor-1alpha (HIF-1alpha) in cancers has been correlated to a more aggressive tumor phenotype. We investigated the effect of HIF-1alpha knockout on the in vitro survival and death of human tongue squamous cell carcinomas (SCC-4 and SCC-9). Under normoxic condition, a basal level of HIF-1alpha protein was constitutively expressed in SCC-9 cells, albeit an undetectable level of HIF-1alpha messages. Exposure to hypoxia induced only a transient increase in mRNA transcript but a prolonged elevation of HIF-1alpha protein and its immediate downstream target gene product, VEGF. Under normoxic or hypoxic conditions, treatment of SCC-9 cells with AS-HIF-1alpha ODN suppressed both constitutive and hypoxia-induced HIF-1alpha expression at both mRNA and protein levels Knockout of HIF-1alpha gene expression via either AS-HIF-1alpha ODN or siRNA (siRNA(HIF-1alpha)) treatment resulted in inhibition of cell proliferation and induced apoptosis in SCC-4 and SCC-9 cells. We also demonstrated that exposure of SCC-9 cells to hypoxia led to a time-dependent increase in the expression of bcl-2 and IAP-2, but not p53. The attenuated levels of bcl-2 and IAP-2, and the enhanced activity of caspase-3 after treatment with AS-HIF-1alpha ODN may contribute partly to the effects of HIF-1alpha blockade on SCC-9 cell death. Collectively, our data suggest that a constitutive or hypoxia-induced expression of HIF-1alpha in SCC-9 and SCC-4 cells is sufficient to confer target genes expression essential for tumor proliferation and survival. As a result, interfering with HIF-1alpha pathways by antisense or siRNA strategy may provide a therapeutic target for human tongue squamous cell carcinomas. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:849 / 857
页数:9
相关论文
共 61 条
[1]  
Aebersold DM, 2001, CANCER RES, V61, P2911
[2]  
Akakura N, 2001, CANCER RES, V61, P6548
[3]   Hypoxia induces the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells -: Protective role in apoptosis [J].
Alvarez-Tejado, M ;
Naranjo-Suárez, S ;
Jiménez, C ;
Carrera, AC ;
Landázuri, MO ;
del Peso, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (25) :22368-22374
[4]   Stabilization of wild-type p53 by hypoxia-inducible factor 1α [J].
An, WG ;
Kanekal, M ;
Simon, MC ;
Maltepe, E ;
Blagosklonny, MV ;
Neckers, LM .
NATURE, 1998, 392 (6674) :405-408
[5]   Phosphatidylinositol 3-kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1α nor sufficient for HIF-1-dependent target gene transcription [J].
Arsham, AM ;
Plas, DR ;
Thompson, CB ;
Simon, MC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (17) :15162-15170
[6]   Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis [J].
Baek, JH ;
Jang, JE ;
Kang, CM ;
Chung, HY ;
Kim, ND ;
Kim, KW .
ONCOGENE, 2000, 19 (40) :4621-4631
[7]  
Birner P, 2000, CANCER RES, V60, P4693
[8]  
Birner P, 2001, CLIN CANCER RES, V7, P1661
[9]   Levels of hypoxia-inducible factor-1α during breast carcinogenesis [J].
Bos, R ;
Zhong, H ;
Hanrahan, CF ;
Mommers, ECM ;
Semenza, GL ;
Pinedo, HM ;
Abeloff, MD ;
Simons, JW ;
van Diest, PJ ;
van der Wall, E .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (04) :309-314
[10]   Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies [J].
Brown, JM .
MOLECULAR MEDICINE TODAY, 2000, 6 (04) :157-162